Publications

Shinya Yamanaka, MD, PhDSilva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A. Nanog is the gateway to the pluripotent ground state. Cell. 2009 Aug 21; 138(4):722-37. View in: PubMed
Shinya Yamanaka, MD, PhDEfficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. View in: PubMed
Shinya Yamanaka, MD, PhDHong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009 Aug 27; 460(7259):1132-5. View in: PubMed
Shinya Yamanaka, MD, PhDG(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. View in: PubMed
Shinya Yamanaka, MD, PhDOrderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. View in: PubMed
Shinya Yamanaka, MD, PhDYokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H, Yamanaka S, Nakahata T, Heike T. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun. 2009 Sep 25; 387(3):482-8. View in: PubMed
Shinya Yamanaka, MD, PhDInduced pluripotent stem cells and reprogramming: seeing the science through the hype. View in: PubMed
Shinya Yamanaka, MD, PhDMiura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009 Aug; 27(8):743-5. View in: PubMed
Shinya Yamanaka, MD, PhDEkiden to iPS Cells. View in: PubMed
Shinya Yamanaka, MD, PhDYamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009 Jul 2; 460(7251):49-52. View in: PubMed